Proteins

Items 171-180 of 236

per page
Set Descending Direction
  1. IL-7 (human) (monomeric):Fc-KIH (human) (rec.)
    AG-40B-0238
    AG-40B-0238-C05050 µg
    CHF 440.00
    IL-7 (human) (monomeric):Fc-KIH (human) (rec.)
  2. IL-7 (mouse) (monomeric):Fc (LALA-PG)-KIH (human) (rec.)
    AG-40B-0256
    AG-40B-0256-C05050 µg
    CHF 440.00
    IL-7 (mouse) (monomeric):Fc (LALA-PG)-KIH (human) (rec.)
  3. Irisin (rec.) (CHO)
    AG-40B-0136
    AG-40B-0136-C01010 µg
    CHF 380.00
    AG-40B-0136-30103 x 10 µg
    CHF 760.00
  4. Irisin (rec.) (untagged) (E.coli)
    AG-40B-0103
    AG-40B-0103-C01010 µg
    CHF 210.00
    AG-40B-0103-30103 x 10 µg
    CHF 420.00
  5. Irisin:Fc (human) (rec.)
    AG-40B-0115
    AG-40B-0115-C01010 µg
    CHF 130.00
    AG-40B-0115-50105 x 10 µg
    CHF 390.00

    Replaced by AG-40B-0246

  6. Isthmin-1 (mouse) (rec.) (His)
    AG-40B-0215
    AG-40B-0215-C05050 µg
    CHF 330.00
    AG-40B-0215-30503 x 50 µg
    CHF 660.00
  7. Jagged-1 (mouse):Fc (human) (rec.)
    AG-40A-0157T
    AG-40A-0157T-C01010 µg
    CHF 235.00
    AG-40A-0157T-C05050 µg
    CHF 480.00
  8. LAG-3 (human):Fc (human) (rec.)
    AG-40B-0031
    AG-40B-0031-C05050 µg
    CHF 395.00
    Binding of LAG-3 (human):Fc (human) (rec.) (Prod. No. AG-40B-0031) on dendritic and B cells. Method: Monocyte-derived immature DC (iDC), DC matured for 48h with LPS (mDC) and EBV-transformed B-cells are incubated with either an anti-
  9. LAG-3 (mouse):Fc (mouse) (rec.)
    AG-40B-0039
    AG-40B-0039-C05050 µg
    CHF 410.00
  10. LIF (human) (rec.)
    AG-40B-0093
    AG-40B-0093-C01010 µg
    CHF 170.00
    AG-40B-0093-30103 x 10 µg
    CHF 335.00
    AG-40B-0093-C100100 µg
    CHF 1'010.00
    Figure: Human Leukemia Inhibitory Factor (LIF) (rec.) (AG-40B-0093) maintains pluripotency of mouse ES cells. Method: Mouse ES oct4 GFP cells were cultured for 3 days in the presence of the indicated concentrations of LIF and followed

Items 171-180 of 236

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.